Javen Liew

Javen Liew has a diverse work experience spanning various roles in the finance and accounting sector. In 2004, Javen began their career as an Audit Associate at BDO, followed by a transition to Deloitte Touche Tohmatsu in 2005, where they worked as an Audit Manager for five years. In 2010, Javen joined BT as a Finance Manager in Hong Kong, later progressing to the role of Controller for North East Asia and Japan. From 2017 to 2018, Javen worked as a Finance and Accounting Consultant at DLC before serving as an Interim Assistant Controller at CytomX Therapeutics. In 2018, Javen joined Pliant Therapeutics as an Associate Director and Assistant Controller until 2021 when they took on the position of Director of Accounting and Assistant Controller at Amunix Pharmaceuticals.

Javen Liew studied at The University of Adelaide, where they pursued a Bachelor of Commerce (B.Com.) degree with a focus on Accounting. Javen also attended Eynesbury College and obtained a South Australian Certificate of Education. In addition to their formal education, Javen has obtained certifications such as Microsoft Office Specialist Excel Expert 2013 from Microsoft Office Specialist. Javen has also pursued certifications from CPA Australia and the Hong Kong Institute of Certified Public Accountants (HKICPA). However, the specific details regarding the completion and dates of these certifications are not provided.